c-Jun NH2-terminal kinase is a critical node in the death of CD4+CD8+ thymocytes during Salmonella enterica serovar Typhimurium infection

European Journal of Immunology

Volumn 44, Issue 1, 2014, Pages 137-149

  Deobagkar Lele, Mukta ^a   Victor, Emmanuel S ^a   Nandi, Dipankar ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Cell death; Glucocorticoids; IFN ; JNK activation; Thymic atrophy

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE 3; DEXAMETHASONE; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 1BETA; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; AUTACOID; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GLUCOCORTICOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; MOUTH INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; THYMOCYTE; THYMUS ATROPHY; 129 MOUSE; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; IFN-Γ; IMMUNOLOGY; JNK ACTIVATION; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SALMONELLA TYPHI; THYMUS; TYPHOID FEVER;

CELL DEATH; GLUCOCORTICOIDS; IFN-Γ; JNK ACTIVATION; THYMIC ATROPHY;

ANIMALS; ANTHRACENES; ANTIGENS, CD4; ANTIGENS, CD8; CASPASE 3; CELL DEATH; CELLS, CULTURED; CYTOKINES; INFLAMMATION MEDIATORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; REACTIVE OXYGEN SPECIES; SALMONELLA TYPHI; THYMOCYTES; THYMUS GLAND; TYPHOID FEVER;

EID: 84892472596     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343506     Document Type: Article

References (56)

1. Savino, W., The thymus is a common target organ in infectious diseases. PLoS Pathog. 2006. 2: e62.
2. Dooley, J. and Liston, A., Molecular control over thymic involution: from cytokines and microRNA to aging and adipose tissue. Eur. J. Immunol. 2012. 42: 1073-1079.
3. Nobrega, C., Roque, S., Nunes-Alves, C., Coelho, A., Medeiros, I., Castro, A. G., Appelberg, R. et al., Dissemination of mycobacteria to the thymus renders newly generated T cells tolerant to the invading pathogen. J. Immunol. 2010. 184: 351-358.
4. Mandel, T. E. and Cheers, C., Resistance and susceptibility of mice to bacterial infection: histopathology of listeriosis in resistant and susceptible strains. Infect. Immun. 1980. 30: 851-861.
5. + thymocyte depletion. Microb. Pathog. 2005. 39: 189-196.
6. Borges, M., Barreira-Silva, P., Flórido, M., Jordan, M. B., Correia-Neves, M. and Appelberg, R., Molecular and cellular mechanisms of Mycobacterium avium-induced thymic atrophy. J. Immunol. 2012. 189: 3600-3608.
7. Ross, E. A., Coughlan, R. E., Flores-Langarica, A., Lax, S., Nicholson, J., Desanti, G. E., Marshall, J. L. et al., Thymic function is maintained during Salmonella-induced atrophy and recovery. J. Immunol. 2012. 189: 4266-4274.
8. Deobagkar-Lele, M., Chacko, S. K., Victor, E. S., Kadthur, J. C. and Nandi, D., Interferon γ and glucocorticoid mediated pathways synergize to enhance death of CD4(+) CD8(+) thymocytes during Salmonella enterica serovar Typhimurium infection. Immunology. 2012. 138: 307-321.
9. Crump, J. A. and Mintz, E. D., Global trends in typhoid and paratyphoid fever. Clin. Infect. Dis. 2010. 50: 241-246.
10. Gordon, M. A., Kankwatira, A. M., Mwafulirwa, G., Walsh, A. L., Hopkins, M. J., Parry, C. M., Faragher, E. B. et al., Invasive non-typhoid salmonellae establish systemic intracellular infection in HIV-infected adults: an emerging disease pathogenesis. Clin. Infect. Dis. 2010. 50: 953-962.
11. Godfraind, C., Holmes, K. V. and Coutelier, J. P., Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice. J. Virol. 1995. 69: 6541-6547.
12. Rosenzweig, M., Connole, M., Forand-Barabasz, A., Tremblay, M. P., Johnson, R. P. and Lackner, A. A., Mechanisms associated with thymocyte apoptosis induced by simian immunodeficiency virus. J. Immunol. 2000. 165: 3461-3468.
13. Dion, M. L., Poulin, J. F., Bordi, R., Sylvestre, M., Corsini, R., Kettaf, N., Dalloul, A. et al., HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 2004. 21: 757-768.
14. Ho Tsong Fang, R., Colantonio, A. D. and Uittenbogaart, C. H., The role of the thymus in HIV infection: a 10 year perspective. AIDS 2008. 22: 171-184.
15. van den Brink, M. R., Alpdogan, O. and Boyd, R. L., Strategies to enhance T-cell reconstitution in immuno-compromised patients. Nat. Rev. Immunol. 2004. 4: 856-867.
16. Lee, J. C., Boechat, M. I., Belzer, M., Church, J. A., De Ville, J., Nielsen, K., Weston, S. et al., Thymic volume, T-cell populations, and parameters of thymopoiesis in adolescent and adult survivors of HIV infection acquired in infancy. AIDS 2006. 20: 667-674.
17. Westrop, S. J., Qazi, N. A., Pido-Lopez, J., Nelson, M. R., Gazzard, B., Gotch, F. M. and Imami, N., Transient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllers. PLoS One 2009. 4: e5474.
18. Li, T., Wu, N., Dai, Y., Qiu, Z., Han, Y., Xie, J., Zhu, T. et al., Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy. Clin. Infect. Dis. 2011. 53: 944-951.
19. Garrido, C., Rallón, N., Soriano, V., Lopez, M., Zahonero, N., de Mendoza, C. and Benito, J. M., Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir. AIDS 2012. 26: 551-557.
20. AbuAttieh, M., Bender, D., Liu, E., Wettstein, P., Platt, J. L. and Cascalho, M., Affinity maturation of antibodies requires integrity of the adult thymus. Eur. J. Immunol. 2012. 42: 500-510.
21. Pérez, A. R., Roggero, E., Nicora, A., Palazzi, J., Besedovsky, H. O., Del Rey, A. and Bottasso, O. A., Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav. Immun. 2007. 21: 890-900.
22. Billard, M. J., Gruver, A. L. and Sempowski, G. D., Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses. PLoS One 2011. 6: e17940.
23. Scofield, V. L., Yan, M., Kuang, X., Kim, S. J. and Wong, P. K., The drug monosodium luminol (GVT) preserves crypt-villus epithelial organization and allows survival of intestinal T cells in mice infected with the ts1 retrovirus. Immunol. Lett. 2009. 122: 150-158.
24. Farias-de-Oliveira, D. A., Villa-Verde, D. M., Nunes Panzenhagen, P. H., Silva Dos Santos, D., Berbert, L. R., Savino, W. and de Meis, J., Caspase-8 and caspase-9 mediate thymocyte apoptosis in Trypanosoma cruzi acutely infected mice. J. Leukoc. Biol. 2013. 93: 227-234.
25. Seger, R. and Krebs, E. G., The MAPK signaling cascade. FASEB J. 1995. 9: 726-735.
26. Johnson, G. L. and Lapadat, R., Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002. 298: 1911-1912.
27. Werlen, G., Hausmann, B., Naeher, D. and Palmer, E., Signaling life and death in the thymus: timing is everything. Science 2003. 299: 1859-1863.
28. Sugawara, T., Moriguchi, T., Nishida, E. and Takahama, Y., Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity 1998 9: 565-574.
29. + thymocytes. J. Exp. Med. 1998. 188: 1817-1830.
30. Behrens, A., Sabapathy, K., Graef, I., Cleary, M., Crabtree, G. R. and Wagner, E. F., Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT). Proc. Natl. Acad. Sci. USA 2001. 98: 1769-1774.
31. Dong, C., Yang, D. D., Wysk, M., Whitmarsh, A. J., Davis, R. J. and Flavell, R. A., Defective T cell differentiation in the absence of Jnk1. Science. 1998. 282: 2092-2095.
32. Sabapathy, K., Hu, Y., Kallunki, T., Schreiber, M., David, J. P., Jochum, W., Wagner, E. F. et al., JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 1999. 9: 116-125.
33. Sabapathy, K., Kallunki, T., David, J. P., Graef, I., Karin, M. and Wagner, E. F., c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J. Exp. Med. 2001. 193: 317-328.
34. Clarke, P., Meintzer, S. M., Widmann, C., Johnson, G. L. and Tyler, K. L., Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun. J. Virol. 2001. 75: 11275-11283.
35. + T lymphocytes. Nat. Med. 2010. 16: 329-333.
36. Ceballos-Olvera, I., Chávez-Salinas, S., Medina, F., Ludert, J. E. and del Angel, R. M., JNK phosphorylation, induced during dengue virus infection, is important for viral infection and requires the presence of cholesterol. Virology 2010. 396: 30-36.
37. Procyk, K. J., Rippo, M. R., Testi, R., Hoffmann, F., Parker, P. J. and Baccarini, M., Distinct mechanisms target stress and extracellular signal-activated kinase 1 and Jun N-terminal kinase during infection of macrophages with Salmonella. J. Immunol. 1999. 163: 4924-4930.
38. Wain, J., Diep, T. S., Ho, V. A., Walsh, A. M., Nguyen, T. T., Parry, C. M., and White, N. J., Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J. Clin. Microbiol. 1998. 36: 1683-1687.
39. +/+ mice and can be reactivated by IFN gamma neutralization. J. Exp. Med. 2004. 199: 231-241.
40. Ashwell, J. D., Lu, F. W. and Vacchio, M. S., Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 2000. 18: 309-345.
41. Liang, Y., Hudson, L. C., Levy, J. K., Ritchey, J. W., Tompkins, W. A. and Tompkins, M. B., T cells overexpressing interferon-gamma and interleukin-10 are found in both the thymus and secondary lymphoid tissues of feline immunodeficiency virus-infected cats. J. Infect. Dis. 2000. 181: 564-575.
42. Boehm, U., Klamp, T., Groot, M. and Howard, J. C., Cellular responses to interferon-gamma. Annu. Rev. Immunol. 1997. 15: 749-795.
43. Heidari, N., Miller, A. V., Hicks, M. A., Marking, C. B. and Harada, H., Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells. Cell. Death. Dis. 2012. 3: e349. doi:10.1038/cddis.2012.89.
44. Kharbanda, S., Saxena, S., Yoshida, K., Pandey, P., Kaneki, M., Wang, Q., Cheng, K. et al., Translocation of SAPK/JNK to mitochondria and interaction with Bcl-xL in response to DNA damage. J. Biol. Chem. 2000. 275: 322-327.
45. Dhanasekaran, D. N. and Reddy, E. P., JNK signaling in apoptosis. Oncogene 2008. 27: 6245-6251.
46. Latchoumycandane, C., Seah, Q. M., Tan, R. C., Sattabongkot, J., Beerheide, W. and Boelsterli, U. A., Leflunomide or A77 1726 protect from acetaminophen-induced cell injury through inhibition of JNK-mediated mitochondrial permeability transition in immortalized human hepatocytes. Toxicol. Appl. Pharmacol. 2006. 217: 125-133.
47. Zhang, S., Wang, X. L., Gan, Y. H. and Li, S. L., Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cells. Anticancer Drugs 2010. 21: 678-686.
48. Chao, D. T. and Korsmeyer, S. J., BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 1998. 16:395-419.
49. Hammaker, D. R., Boyle, D. L., Chabaud-Riou, M. and Firestein, G. S., Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis. J. Immunol. 2004. 172: 1612-1618.
50. Han, Z., Boyle, D. L., Chang, L., Bennett, B., Karin, M., Yang, L., Manning, A. M. et al., c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 2001. 108: 73-81.
51. Hommes, D., van den Blink, B., Plasse, T., Bartelsman, J., Xu, C., Macpherson, B., Tytgat, G. et al., Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology. 2002. 122: 7-14.
52. Manning, A. M. and Davis, R. J., Targeting JNK for therapeutic benefit: from junk to gold? Nat. Rev. Drug. Discov. 2003. 2: 554-565.
53. Bogoyevitch, M. A., Boehm, I., Oakley, A., Ketterman, A. J. and Barr, R. K., Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim. Biophys. Acta 2004. 1697: 89-101.
54. -/- mice. Immunobiology 2012. 217: 354-362.
55. Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C. et al., SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 2001. 98: 13681-13686.
56. Patil, V., Kumar, A., Kuruppath, S. and Nandi, D., Peptidase N encoded by Salmonella enterica serovar Typhimurium modulates systemic infection in mice. FEMS Immunol. Med. Microbiol. 2007. 51: 431-442.